SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-009327
Filing Date
2021-05-06
Accepted
2021-05-06 16:27:22
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ngm-20210331.htm   iXBRL 10-Q 1351812
2 EX-10.2 ngm-20210331x10qex102.htm EX-10.2 14182
3 EX-10.3 ngm-20210331x10qex103.htm EX-10.3 16475
4 EX-31.1 ngm-20210331x10qex311.htm EX-31.1 10098
5 EX-31.2 ngm-20210331x10qex312.htm EX-31.2 10115
6 EX-32.1 ngm-20210331x10qex321.htm EX-32.1 7550
12 GRAPHIC ngm_logoxposxcmyk1.jpg GRAPHIC 358346
13 GRAPHIC ngm_logoxposxcmyk1a.jpg GRAPHIC 358346
  Complete submission text file 0001628280-21-009327.txt   6673074

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20210331.xsd EX-101.SCH 39325
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20210331_cal.xml EX-101.CAL 57472
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20210331_def.xml EX-101.DEF 163080
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20210331_lab.xml EX-101.LAB 484001
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20210331_pre.xml EX-101.PRE 299942
14 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20210331_htm.xml XML 871666
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38853 | Film No.: 21898240
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences